Article
Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Nov 2020
Ortega Morán L, García Alfonso P, Aguilar Caballero I, Morón García B, Tirado Anula V, de Toro Carmena M, Soto Alsar J, Gutiérrez Alonso N, Bringas Beranek M, Martín Jiménez M, Muñoz Martín A J
Abstract excerpt
BACKGROUND: There are conflicting data regarding the role of KRAS mutation on the risk of venous thromboembolism (VTE) in colorectal cancer (CRC) patients. Moreover, the role of other biomarkers such as NRAS or BRAF has not been studied. PURPOSE: To analyze the incidence of VTE in a cohort of patients with CRC based on KRAS, NRAS, and BRAF status. METHODS: We performed a retrospective review of patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.